Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

Recruiting in Palo Alto (17 mi)

+15 other locations

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: AIDS Malignancy Consortium

No Placebo Group

Trial Summary

What is the purpose of this trial?

This study is being done to understand how many people with HIV (PWH) present for cancer care across the AIDS Malignancy Consortium in the United States and if there are reasons that some PWH choose to participate, or not in cancer clinical trials. Optional quality of life surveys will be used to learn more about how HIV and cancer and HIV and cancer treatment affect people.

Research Team

Eligibility Criteria

Inclusion Criteria

Participant can understand and is willing to sign a written informed consent document.

Documentation of an HIV diagnosis in the medical record by a licensed health care provider;

Documentation of receipt of antiretroviral therapy (ART) (i.e., at least two different medications that do not constitute a prescription for pre-exposure prophylaxis [PrEP]) by a licensed health care provider. Documentation may be a record of an ART prescription in the medical record, a written prescription in the name of the participant for ART, or pill bottles for ART with a label showing the participant's name;

See 7 more

Treatment Details

Interventions

Non-Interventional (Other)
Non-Interventional Follow-up (Other)
Screening Tool (Behavioural Intervention)

Participant Groups

3Treatment groups

Experimental Treatment

Group I: Prior cancerExperimental Treatment1 Intervention

Prior diagnosis (within 5 years), in remission - Not currently on cancer treatment other than ART or maintenance therapy.

Group II: New, primary or recurrent diseaseExperimental Treatment2 Interventions

Considering or currently receiving cancer treatment

Group III: Metastic or locally advanced cancerExperimental Treatment2 Interventions

This includes cases for which there are no current definitive therapy options for cure (i.e., inoperable) but may be considered for non-standard / non-curative therapies.